Sight Sciences (SGHT) EPS (Weighted Average and Diluted) (2021 - 2026)
Sight Sciences (SGHT) recorded quarterly EPS (Weighted Average and Diluted) of -$0.24 in Q1 2026, down 200.0% quarter-over-quarter from -$0.08 in Q4 2025, and up 14.29% on a YoY basis from -$0.21 in Q1 2025.
Sight Sciences (SGHT) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Sight Sciences' EPS (Weighted Average and Diluted) history runs 6 years deep, the most recent figure standing at -$0.24 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 14.29% year-over-year to -$0.24; the TTM figure through Mar 2026 stood at -$0.71 (up 28.28% YoY), while the FY2025 annual figure was -$0.74, up 28.16% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.24 for Q1 2026 at Sight Sciences, down from -$0.08 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.08 in Q4 2025 to a low of -$0.5 in Q2 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.29 across 5 years, with a median of -$0.27 in 2023.
- The sharpest annual moves came in 2022 and 2025: EPS (Weighted Average and Diluted) sank 1850.0% in 2022, then surged 66.67% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.35 in 2022, then jumped by 37.14% to -$0.22 in 2023, then decreased by 9.09% to -$0.24 in 2024, then soared by 66.67% to -$0.08 in 2025, then tumbled by 200.0% to -$0.24 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.24 (Q1 2026), -$0.08 (Q4 2025), and -$0.16 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Sight Sciences | 284.28 Mn | 199.32 Mn | 16.98 Mn | -0.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.24 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | -0.16 |
| Jun 30, 2025 | -0.23 |
| Mar 31, 2025 | -0.28 |
| Dec 31, 2024 | -0.24 |
| Sep 30, 2024 | -0.22 |
| Jun 30, 2024 | -0.25 |
| Mar 31, 2024 | -0.33 |
| Dec 31, 2023 | -0.22 |
| Sep 30, 2023 | -0.27 |
| Jun 30, 2023 | -0.30 |
| Mar 31, 2023 | -0.35 |
| Dec 31, 2022 | -0.35 |
| Sep 30, 2022 | -0.46 |
| Jun 30, 2022 | -0.50 |
| Mar 31, 2022 | -0.49 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | -0.43 |